This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
B Andrews , K Burnand , G Paganga , N Browse , C Rice-Evans , K Sommerville , D Leake & N Taub (1995) Oxidisability of low-density lipoproteins in patients with carotid or femoral artery atherosclerosis. Atherosclerosis 112, 77–84.
RK Berge , L Madsen , H Vaagenes , KJ Tronstad , M Göttlicher & AC Rustan (1999) In contrast with docosahexaenoic acid, eicosapentaenoic acid and hypolipidaemic derivatives decrease hepatic synthesis and secretion of triacylglycerol by decreased diacylglycerol acyltransferase activity and stimulation of fatty acid oxidation. Biochemistry Journal 343, 191–197.
JA Berliner , MC Territo , A Sevanian , S Ramin , JA Kim , B Bamshad , M Esterson & AM Fogelman (1990) Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. Journal of Clinical Investigation 85, 1260–1266.
IR Brude , CA Drevon , I Hjermann , I Seljeflot , S Lund-Katz , K Saarem , B Sandstad , K Solvoll , B Halvorsen , H Arnesen & MS Nenseter (1997) Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants. Arteriosclerosis Thrombosis and Vascular Biology 17, 2576–2588.
JA Conquer & BJ Holub (1997) Dietary docosahexaenoic acid as a source of eicosapentaenoic acid in vegetarians and omnivores. Lipids 32, 314–345.
MH Davidson , KC Maki , JA Kalkowski , EJ Schaefer , SA Torri & KB Drennan (1997) Effects of docosahexaenoic acid on serum lipoproteins in patients with combined hyperlipidaemia: a randomized, double-blind placebo-controlled trial. Journal of the American College of Nutrition 16, 236–243.
J DeGraaf , HLM Haklemmers , MPC Hectors , PNM Demacker , JCM Hendriks & AFH Stalenhoef (1991) Enhanced susceptibility to in vitro oxidation of the dense low-density lipoprotein subfraction in healthy subjects. Arteriosclerosis and Thrombosis 11, 298–306.
H Esterbauer , G Striegl , H Puhl & M Rotheneder (1989) Continuous monitoring of in vitro oxidation of human low-density lipoprotein. Free Radical Research Communications 6, 67–75.
KN Frayn (1998) Non-esterified fatty acid metabolism and postprandial lipaemia. Atherosclerosis 141, S41–S46.
KN Frayn , CM Williams & P Arner (1996) Are increased non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases? Clinical Science 90, 243–253.
GISSI-Prevenzione Investigators (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354, 447–455.
BA Griffin , MJ Caslake , B Yip , GW Tait , CJ Packard & J Shepherd (1990) Rapid isolation of low density lipoprotein subfractions from plasma by density gradient ultracentrifugation. Atherosclerosis 83, 59–67.
BA Griffin , DJ Freeman , GW Tait , J Thomson , MJ Caslake , CJ Packard & J Shepherd (1994) Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 106, 241–253.
BA Griffin , AM Minihane , N Furlonger , C Chapman , M Murphy , D Williams , JJ Wright & CM Williams (1999) Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects. Clinical Science 97, 269–276.
JG Hamilton & K Comai (1988) Separation of neutral lipid, free fatty-acid and phospholipid classes by normal phase HPLC. Lipids 23, 1150–1153.
D Harats , Y Dabach , M Ben-Naim , R Schwartz , EM Berry , O Stein & Y Stein (1991) Fish oil ingestion in smokers and nonsmokers enhances peroxidation of plasma lipoproteins. Atherosclerosis 90, 127–139.
WS Harris (1996) n-3 Fatty acids and lipoproteins: comparison of results from human and animal studies. Lipids 31, 243–252.
MF Hau , AHM Smelt , AJGH Bindels , EJG Sijbrands , A Vander-Laarse , W Onkenhout , W van Duyvenvoorde & HMG Princen (1996) Effects of fish oil on oxidation resistance of VLDL in hypertriglyceridaemic patients. Arteriosclerosis Thrombosis and Vascular Biology 16, 1197–1202.
S Higgins , SN McCarthy , BM Corridan , HM Roche , JMW Wallace , NM O'Brien & PA Morrissey (2000) Measurement of free cholesterol, cholesteryl esters and cholesteryl linoleate hydroperoxide in copper-oxidised low-density lipoprotein in healthy volunteers supplemented with low dose of n-3 polyunsaturated fatty acids. Nutrition Research 20, 1091–1102.
P Holvoet & D Collen (1998) Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis. Atherosclerosis 137, S33–S38.
GS Hughes , TV Ringer , KC Watts , MJ DeLoof , SF Francom & CR Spillers (1990) Fish oil produces an atherogenic lipid profile in hypertensive men. Atherosclerosis 84, 229–237.
M Indu & Ghafoorunissa (1992) n-3 Fatty acids in Indian diets comparison of the effects of precursor alpha-linolenic acid vs product long chain n-3 polyunsaturated fatty acids. Nutrition Research 12, 569–582.
W Jessup , SM Rankin , CV de Whalley , JRS Hoult , J Scott & DS Leake (1990) α-Tocopherol consumption during low density lipoprotein oxidation. Biochemistry Journal 265, 399–405.
I Jialal , CJ Fuller & BA Huet (1995) The effect of α-tocopherol supplementation on LDL-oxidation. Arteriosclerosis Thrombosis and Vascular Biology 15, 190–198.
P Mata , R Alonso , A LopezFarre , JM Ordovas , C Lahoz , C Garces , C Caramelo , R Codoceo , E Blazquez & M deOya (1996) Effect of dietary fat saturation on LDL oxidation and monocyte adhesion to human endothelial cells in vitro. Arteriosclerosis Thrombosis and Vascular Biology 16, 1347–1355.
AM Minihane , S Khan , EC Leigh-Firbank , P Talmud , JW Wright , MC Murphy , BA Griffin & CM Williams (2000 a) ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype. Arteriosclerosis Thrombosis and Vascular Biology 20, 1990–1997.
AM Minihane , S Khan , PJ Talmud , DL Williams , JW Wright , MC Murphy , BA Griffin & CM Williams (2000 b) Lack of association between lipaemia and central adiposity in subjects with an atherogenic lipoprotein phenotype (ALP). International Journal of Obesity 24, 1097–1106.
TA Mori , GF Watts , V Burke , E Hilme , IB Puddey & LJ Beilin (2000 b) Differential effects of eicosapentaenoic acid on reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Circulation 102, 1264–1269.
GJ Nelson , PC Schmidt , GL Bartolini , DS Kelley & D Kyle (1997) The effect of dietary docosahexaenoic acid on plasma lipoproteins and tissue fatty acid composition in humans. Lipids 32, 1137–1146.
PJ Nestel , WE Connor , MR Reardon , S Connor , S Wong & R Boston (1984) Suppression by diets rich in fish oil of very low density lipoprotein production in man. Journal of Clinical Investigation 74, 72–89.
P Nilsson-Ehle , A Garfinkel & MC Schotz (1980) Lipolytic enzymes and plasma lipoprotein metabolism. Annual Reviews in Biochemistry 49, 667–693.
GS Rambjør , AI Wålen , SL Windsor & WS Harris (1996) Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect of fish oil in humans. xLipids 31, S45–S49.
P Reaven , S Parthasarathy , BJ Grasse , E Miller , D Steinberg & JL Witztum (1993) Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects. Journal of Clinical Investigation 91, 668–676.
PD Reaven , BJ Grasse & DL Tribble (1994) Effects of linoleate-enriched and oleate-enriched diets in combination with α-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans. Arteriosclerosis and Thrombosis 14, 557–566.
J Regnstrom , J Nilsson , P Tornvall , C Landou & A Hamsten (1992) Susceptibility to low density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 339, 1183–1186.
TAB Sanders & F Roshanai (1983) The influence of different types of omega-3 polyunsaturated fatty acids on blood-lipids and platelet-function in healthy volunteers. Clinical Science 64, 91–99.
D Steinberg (1997) Low density lipoprotein oxidation and its pathobiological significance. Journal of Biological Chemistry 272, 20963–20966.
S Toshima , A Hasegawa , M Kurabayashi , H Itabe , T Takano , J Sugano , K Shimamura , I Michishita , T Suzuki & R Nagai (2000) Circulating oxidized low density lipoprotein levels: a biochemical marker for coronary heart disease. Arteriosclerosis Thrombosis and Vascular Biology 20, 2243–2247.
HM Vidgren , Ågren JJ, U Schwab , T Rissanen , O Hanninen & MIJ Uusitupa (1997) Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men. Lipids 32, 697–705.
C Von Schacky & PC Weber (1985) Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans. Journal of Clinical Investigation 76, 2246–2250.
WH Wong , EA Fisher & JB Marsh (1989) Effects of eicosapentaenoic acid and docosahexaenoic acid on apolipoprotein mRNA and secretion of very low density lipoprotein in HepG2 cells. Arteriosclerosis 9, 836–841.
SD Zuijdgeest-van Leeuwen , PC Dagnelie , T Rietveld , JWO van den Berg & JHP Wilson (1999) Incorporation and washout of orally administered n-3 fatty acid ethyl esters in different plasma lipid fractions. British Journal of Nutrition 82, 481–488.